Network-based Assessment of HDAC6 Activity Predicts Preclinical and Clinical Responses to the HDAC6 Inhibitor Ricolinostat in Breast Cancer
Tizita Z. Zeleke,Qingfei Pan,Codruta Chiuzan,Maika Onishi,Yuxin Li,Haiyan Tan,Mariano J. Alvarez,Erin Honan,Min Yang,Pei Ling Chia,Partha Mukhopadhyay,Sean Kelly,Ruby Wu,Kathleen Fenn,Meghna S. Trivedi,Melissa Accordino,Katherine D. Crew,Dawn L. Hershman,Matthew Maurer,Simon Jones,Anthony High,Junmin Peng,Andrea Califano,Kevin Kalinsky,Jiyang Yu,Jose Silva NATURE CANCER（2023）
关键词
Breast cancer,Targeted therapies,Tumour biomarkers,Life Sciences,general
AI 理解论文
溯源树
样例
